Covered recipient · General Payments record
FAYYAZ MAHMOOD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$1,039.11
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $233.32 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $73.60 | 3 |
| Lundbeck LLC | $60.47 | 2 |
| PFIZER INC. | $23.55 | 1 |
| Neurelis, Inc. | $20.36 | 1 |
| Neurocrine BioSciences, Inc. | $19.66 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.22 | 1 |
| TG THERAPEUTICS, INC. | $17.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation | $19.72 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015588471 | CMS |
| Celgene Corporation | $27.50 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015588475 | CMS |
| Celgene Corporation | $26.38 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015588511 | CMS |
| Lundbeck LLC | $31.06 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032279691 | CMS |
| Lundbeck LLC | $29.41 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032279697 | CMS |
| Neurelis, Inc. | $20.36 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050923251 | CMS |
| Neurocrine Biosciences, Inc. | $19.66 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052084279 | CMS |
| Novartis Pharmaceuticals Corporation | $18.22 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992920345 | CMS |
| PFIZER INC. | $23.55 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049509847 | CMS |
| TG Therapeutics, Inc. | $17.46 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051501723 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.